Description: Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company is developing MosaiQ, a proprietary technology platform, which provides tests for blood grouping and serological disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.
Home Page: www.quotientbd.com
QTNT Technical Analysis
Business Park Terre Bonne
Eysins,
1262
Switzerland
Phone:
11 41 22 716 9800
Officers
| Name | Title |
|---|---|
| Mr. Manuel O. Mendez | CEO & Director |
| Mr. Ali Kiboro | Chief Financial Officer |
| Mr. Mohammad El Khoury | Chief Commercial Officer |
| Ms. Vittoria Bonasso | Head of Fin., Group Controller & Principal Accounting Officer |
| Dr. Michael Hausmann | Chief Technology Officer |
| Dr. Christine Ginocchio | Chief Scientific & Medical Officer |
| Ms. Viviane Montarnal | Head of Legal Affairs & Compliance |
| Ms. Hyatt Antognini-Amin | Head of Corp. Communications |
| Mr. Christian Albrich | Chief People Officer |
| Mr. Esteban Uriarte | Chief Manufacturing Operations Officer |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Supplies |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 54.8734 |
| Price-to-Sales TTM: | 0.031 |
| IPO Date: | 2014-04-25 |
| Fiscal Year End: | March |
| Full Time Employees: | 450 |